01.01.07
In one of the last actions before the U.S. Senate in the 109th Congress, Andrew von Eschenbach, MD, was confirmed as Commissioner of the FDA. He has served as the Acting Commissioner since the September 2005 resignation of Lester Crawford, DVM. Dr. Von Eschenbach was previously director of the National Cancer Institute